rs11845676

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014844.5(TECPR2):​c.1156G>A​(p.Ala386Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0118 in 1,603,288 control chromosomes in the GnomAD database, including 613 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.038 ( 306 hom., cov: 32)
Exomes 𝑓: 0.0090 ( 307 hom. )

Consequence

TECPR2
NM_014844.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.654

Publications

6 publications found
Variant links:
Genes affected
TECPR2 (HGNC:19957): (tectonin beta-propeller repeat containing 2) The protein encoded by this gene is a member of the tectonin beta-propeller repeat-containing (TECPR) family, and contains both TECPR and tryptophan-aspartic acid repeat (WD repeat) domains. This gene has been implicated in autophagy, as reduced expression levels of this gene have been associated with impaired autophagy. Recessive mutations in this gene have been associated with a hereditary form of spastic paraparesis (HSP). HSP is characterized by progressive spasticity and paralysis of the legs. There is also some evidence linking mutations in this gene with birdshot chorioretinopathy (BSCR), which results in inflammation of the choroid and retina. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
TECPR2 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 49
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017033517).
BP6
Variant 14-102431867-G-A is Benign according to our data. Variant chr14-102431867-G-A is described in ClinVar as [Benign]. Clinvar id is 415302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.117 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TECPR2NM_014844.5 linkc.1156G>A p.Ala386Thr missense_variant Exon 8 of 20 ENST00000359520.12 NP_055659.2 O15040-1
TECPR2NM_001172631.3 linkc.1156G>A p.Ala386Thr missense_variant Exon 8 of 17 NP_001166102.1 O15040-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TECPR2ENST00000359520.12 linkc.1156G>A p.Ala386Thr missense_variant Exon 8 of 20 1 NM_014844.5 ENSP00000352510.7 O15040-1
TECPR2ENST00000558678.1 linkc.1156G>A p.Ala386Thr missense_variant Exon 8 of 17 1 ENSP00000453671.1 O15040-2

Frequencies

GnomAD3 genomes
AF:
0.0382
AC:
5817
AN:
152204
Hom.:
306
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.120
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0192
Gnomad ASJ
AF:
0.0248
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00352
Gnomad FIN
AF:
0.00160
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.00561
Gnomad OTH
AF:
0.0315
GnomAD2 exomes
AF:
0.0138
AC:
3437
AN:
248572
AF XY:
0.0113
show subpopulations
Gnomad AFR exome
AF:
0.123
Gnomad AMR exome
AF:
0.0106
Gnomad ASJ exome
AF:
0.0244
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00153
Gnomad NFE exome
AF:
0.00587
Gnomad OTH exome
AF:
0.0131
GnomAD4 exome
AF:
0.00904
AC:
13115
AN:
1450966
Hom.:
307
Cov.:
31
AF XY:
0.00838
AC XY:
6027
AN XY:
719078
show subpopulations
African (AFR)
AF:
0.121
AC:
4014
AN:
33272
American (AMR)
AF:
0.0122
AC:
541
AN:
44474
Ashkenazi Jewish (ASJ)
AF:
0.0249
AC:
649
AN:
26056
East Asian (EAS)
AF:
0.0000254
AC:
1
AN:
39354
South Asian (SAS)
AF:
0.00258
AC:
222
AN:
85972
European-Finnish (FIN)
AF:
0.00152
AC:
81
AN:
53250
Middle Eastern (MID)
AF:
0.00907
AC:
52
AN:
5732
European-Non Finnish (NFE)
AF:
0.00613
AC:
6762
AN:
1103078
Other (OTH)
AF:
0.0133
AC:
793
AN:
59778
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
743
1487
2230
2974
3717
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
336
672
1008
1344
1680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0382
AC:
5822
AN:
152322
Hom.:
306
Cov.:
32
AF XY:
0.0370
AC XY:
2753
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.119
AC:
4960
AN:
41564
American (AMR)
AF:
0.0191
AC:
293
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0248
AC:
86
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5180
South Asian (SAS)
AF:
0.00331
AC:
16
AN:
4830
European-Finnish (FIN)
AF:
0.00160
AC:
17
AN:
10624
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.00562
AC:
382
AN:
68032
Other (OTH)
AF:
0.0312
AC:
66
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
263
526
790
1053
1316
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0136
Hom.:
163
Bravo
AF:
0.0439
TwinsUK
AF:
0.00485
AC:
18
ALSPAC
AF:
0.00778
AC:
30
ESP6500AA
AF:
0.123
AC:
541
ESP6500EA
AF:
0.00721
AC:
62
ExAC
AF:
0.0157
AC:
1910
Asia WGS
AF:
0.00722
AC:
26
AN:
3478
EpiCase
AF:
0.00763
EpiControl
AF:
0.00753

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia 49 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:1
Apr 20, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Hereditary spastic paraplegia Benign:1
Dec 10, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
5.7
DANN
Benign
0.96
DEOGEN2
Benign
0.0022
T;.
Eigen
Benign
-0.51
Eigen_PC
Benign
-0.39
FATHMM_MKL
Benign
0.44
N
LIST_S2
Benign
0.57
T;T
MetaRNN
Benign
0.0017
T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.79
N;N
PhyloP100
0.65
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.21
N;N
REVEL
Benign
0.043
Sift
Benign
0.54
T;T
Sift4G
Benign
0.64
T;T
Polyphen
0.0010
B;.
Vest4
0.021
MPC
0.30
ClinPred
0.0024
T
GERP RS
4.2
Varity_R
0.025
gMVP
0.26
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11845676; hg19: chr14-102898204; API